Search results for:
brivaracetam
brivaracetam
| Drug Name |
Form |
Strength |
ARHS |
Blue Ridge |
Caldwell |
Chatham |
Johnston |
Lenoir |
Medical Center |
Nash |
Pardee |
Rex |
Rockingham |
Southeastern |
Wayne |
Youth Behavioral Health |
| Brivaracetam |
SOLUTION, INTRAVENOUS |
10 mg/mL (5 mL) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Brivaracetam |
TABLET, ORAL |
50 mg |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Brivaracetam |
TABLET, ORAL |
100 mg |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Last updated: Nov. 17, 2025
UNC Health
System Formulary Restriction:
Use of brivaracetam injection is restricted to patients with refractory status epilepticus who have failed levetiracetam AND
one of the following:
Use of IV formulation is limited to a maximum of 3 days, whereby the patient will transition to enteral formulations
Tablets are film-coated to mask bitterness; crushing does not impact absorption
Med Center
UNC Medical Center Formulary Restrictions